110
Participants
Start Date
September 11, 2007
Primary Completion Date
May 31, 2011
Study Completion Date
February 7, 2018
HKI-272
Paclitaxel
UNIMED Medical Institute, Hong Kong
Institut Jules Bordet Unite du Chimiotherapie, Brussels
Oncologisch Centrum GZA - Location St Augustinus, Wilrijk
AZ Groeninge Campus Maria's Voorzienigheid (MV), Kortrijk
Universitair Ziekenhuis Gent, Ghent
Columbia University Medical Center, New York
Mid-Michigan Physicians-HOS Division, Lansing
Oncology Care Associates, Saint Joseph
City Multifield Clinical Hospital #4 Department of chemotherapy, Dnipropetrovs'k State Medical Academy, Chair of Oncology and Medical Radiology, Dnipropetrovsk
CTRC at The University of Texas Health Science Center, San Antonio
State Oncological Regional Treatment and Diagnostic Center Department of chemotherapy, Lviv
Scripps, Clinic General, La Jolla
Moores UC San Diego Cancer Center, La Jolla
Sharp Memorial Hospital, San Diego
Cancer Hospital, Chinese Academy of Medical Sciences, Beijing
Peking Union Medical College Hospital of Chinese Academy of Medical Sciences, Beijing
The Hospital Affiliated Academy Military Medical Science, Chinese People's Liberation Army, Beijing
Chinese People's Liberation Army General Hospital, Beijing
Tianjin Cancer Hospital, Tianjin
Tianjin Union Medicine Center Department of Oncology, Tianjin
Birla Cancer Centre, S.M.S. Medical College & Hospital, Jaipur
Tata Memorial Hospital, Mumbai
Jehangir Clinical Development Centre, Jehangir Hospital Premises, Pune
M.M.F. Joshi Hospital & Ratna Memorial Hospital, Pune
Boston University Medical Center, Boston
Princess Margaret Hospital University Health Network, Toronto
Department of Medicine, Queen Mary Hospital, Hong Kong
Department of Surgery Queen Mary Hospital, Hong Kong
Wojewodzki Szpital Specjalistyczny im. Ludwika Rydygiera, Oddzial Onkologii, Krakow
Oddzial Chemioterapii Centrum Onkologii Ziemii Lubelskiej, Lublin
Yonsei University Health System - Severance Hospital, Seoul
Asan Medical Center, Division of Oncology, Department of Internal Medicine, Seoul
Puma Biotechnology, Inc.
INDUSTRY